VisionTree®, a leader in cloud-based, patient-reported outcomes, patient engagement and multi-center research/registry solutions, is pleased to announce its participation at the 'ESTRO 35' conference in Turin, Italy, April 29 - May 3, 2016.
VisionTree will be demonstrating its VisionTree Optimal Care™ (VTOC) v5.0 platform, as a proven, robust oncology solution for patient-reported outcomes, research/registry initiatives and Meaningful Use workflow optimization. The VTOC patient portal is ARRA HITECH certified for Meaningful Use Stages 1 and 2, interoperable with any HIS or OIS for your free-standing cancer center or integrated with your hospital enterprise.
VTOC features highlighted at the meeting include:
Implemented at 600+ sites, including 400+ oncology programs and 8 of 10 U.S. & World Report Hospitals, in 12+ countries with 2.5M+ patient users, VTOC has delivered the following proven results:
To schedule a one-on-one demo/meeting at 'ESTRO 35' with the VisionTree team, please contact us at: email@example.com
To learn more about how VTOC can improve your compliance for collecting patient reported outcomes, multi-center research/registry initiatives, integrated Meaningful Use and population health solutions, please visit us at: www.visiontree.com, or set-up a specific webinar time for your organization at: firstname.lastname@example.org
VisionTree Software, Inc. is a leader in cloud-based, patient-centered health electronic medical records, communication and population health data management systems. The VisionTree Optimal Care™ (VTOC) patient data management and workflow platform is MACRA compliant as a modular EHR and implemented at over 600 sites with 2.5M+ patients.
The VTOC platform is used for multi-center research, registries and population health initiatives across multiple domains. VisionTree's customer base consists of leading academic and community centers, research organizations and medical societies globally including 8 of the top 10 U.S. News and World Report hospitals.